FR2533439B1 - Nouvelles compositions pharmaceutiques a base de cis-platine-ii-diammino-dichlorure et procede pour les preparer - Google Patents

Nouvelles compositions pharmaceutiques a base de cis-platine-ii-diammino-dichlorure et procede pour les preparer

Info

Publication number
FR2533439B1
FR2533439B1 FR8314772A FR8314772A FR2533439B1 FR 2533439 B1 FR2533439 B1 FR 2533439B1 FR 8314772 A FR8314772 A FR 8314772A FR 8314772 A FR8314772 A FR 8314772A FR 2533439 B1 FR2533439 B1 FR 2533439B1
Authority
FR
France
Prior art keywords
diammino
platin
dichloride
cis
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8314772A
Other languages
English (en)
Other versions
FR2533439A1 (fr
Inventor
Gaetano Battelli
Diego Oldani
Alessandro Rigamonti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of FR2533439A1 publication Critical patent/FR2533439A1/fr
Application granted granted Critical
Publication of FR2533439B1 publication Critical patent/FR2533439B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8314772A 1982-09-23 1983-09-16 Nouvelles compositions pharmaceutiques a base de cis-platine-ii-diammino-dichlorure et procede pour les preparer Expired FR2533439B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento

Publications (2)

Publication Number Publication Date
FR2533439A1 FR2533439A1 (fr) 1984-03-30
FR2533439B1 true FR2533439B1 (fr) 1986-08-14

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8314772A Expired FR2533439B1 (fr) 1982-09-23 1983-09-16 Nouvelles compositions pharmaceutiques a base de cis-platine-ii-diammino-dichlorure et procede pour les preparer

Country Status (20)

Country Link
US (1) US4670262A (fr)
JP (1) JPS5978117A (fr)
AT (1) AT382077B (fr)
AU (1) AU559499B2 (fr)
BE (1) BE897761A (fr)
CA (1) CA1211372A (fr)
CH (1) CH655852A5 (fr)
DE (1) DE3333024A1 (fr)
DK (1) DK157168C (fr)
FI (1) FI78236C (fr)
FR (1) FR2533439B1 (fr)
GB (1) GB2127291B (fr)
GR (1) GR79055B (fr)
IE (1) IE56173B1 (fr)
IL (1) IL69752A (fr)
IT (1) IT1153974B (fr)
NL (1) NL8303211A (fr)
SE (1) SE464061B (fr)
SU (1) SU1424722A3 (fr)
ZA (1) ZA836904B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
US4696918A (en) * 1984-11-02 1987-09-29 Johnson Matthey Public Limited Company Solubilized platinum compound
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
WO1994005299A1 (fr) * 1992-09-04 1994-03-17 Fuji Kagaku Kogyo Kabushiki Kaisha Compositions medicinales
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
SI1229922T1 (sl) * 1999-11-15 2008-04-30 Pharma Mar Sa Zdravljenje raka z aplidinom
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
CN1479622A (zh) * 2000-10-12 2004-03-03 联合使用阿普里汀和肌肉保护剂来治疗癌症
DK1355910T3 (da) 2001-01-25 2011-06-27 Us Of America Represented By The Secretary Dept Of Health And Human Services Formulering af borsyreforbindelser
WO2003026642A1 (fr) * 2001-09-21 2003-04-03 Sumitomo Pharmaceuticals Co., Ltd. Preparation pharmaceutique lyophilisee
EP1435991B1 (fr) * 2001-10-19 2008-10-15 Pharma Mar, S.A. Utilisation d'aplidine pour le traitement du cancer du pancreas
JP2006519848A (ja) * 2003-03-12 2006-08-31 ファルマ・マール・ソシエダード・アノニマ 改良された抗腫瘍治療
AU2004218883B2 (en) * 2003-03-12 2009-10-01 Dana-Farber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
DK1523984T3 (da) * 2003-10-13 2007-03-26 Zoser B Salama Farmaceutisk sammensætning indeholdende oxoplatin og dettes salte
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8258098B2 (en) * 2006-02-28 2012-09-04 Pharma Mar, S.A. Antitumoral treatments
US20100240595A1 (en) * 2007-10-19 2010-09-23 Pharma Mar ,S.A. Improved Antitumoral Treatments
WO2009111698A1 (fr) * 2008-03-07 2009-09-11 Pharma Mar, S.A. Traitements améliorés contre le cancer
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
EP2889029A1 (fr) 2008-09-25 2015-07-01 Cephalon, Inc. Formulations liquides de bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
CA1119954A (fr) * 1978-05-30 1982-03-16 Edmund S. Granatek Solution aqueuse de cisplatine
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
CA1162479A (fr) * 1980-03-31 1984-02-21 Murray A. Kaplan Compose pharmaceutique contenant du cisplatine

Also Published As

Publication number Publication date
SU1424722A3 (ru) 1988-09-15
US4670262A (en) 1987-06-02
DK424383A (da) 1984-03-24
JPS5978117A (ja) 1984-05-04
DK157168C (da) 1990-04-09
IT8223396A0 (it) 1982-09-23
FI78236B (fi) 1989-03-31
SE464061B (sv) 1991-03-04
FI78236C (fi) 1989-07-10
FR2533439A1 (fr) 1984-03-30
DK424383D0 (da) 1983-09-16
FI833300A (fi) 1984-03-24
FI833300A0 (fi) 1983-09-15
SE8304920L (sv) 1984-03-24
GR79055B (fr) 1984-10-02
IE56173B1 (en) 1991-05-08
IL69752A0 (en) 1983-12-30
SE8304920D0 (sv) 1983-09-13
IL69752A (en) 1986-07-31
BE897761A (fr) 1984-01-02
GB8324380D0 (en) 1983-10-12
NL8303211A (nl) 1984-04-16
DE3333024A1 (de) 1984-03-29
ATA326283A (de) 1986-06-15
AU1908983A (en) 1984-03-29
CH655852A5 (de) 1986-05-30
AT382077B (de) 1987-01-12
IE832172L (en) 1984-03-23
AU559499B2 (en) 1987-03-12
IT1153974B (it) 1987-01-21
CA1211372A (fr) 1986-09-16
GB2127291B (en) 1986-01-15
DK157168B (da) 1989-11-20
GB2127291A (en) 1984-04-11
ZA836904B (en) 1984-10-31

Similar Documents

Publication Publication Date Title
FR2533439B1 (fr) Nouvelles compositions pharmaceutiques a base de cis-platine-ii-diammino-dichlorure et procede pour les preparer
FR2559064B1 (fr) Composition pharmaceutique a biodisponibilite elevee et procede pour la preparer
BE844452A (fr) Granules et comprimes d'acide l-ascorbique et procede pour les preparer
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
YU44678B (en) Process for producing n-(4-(3-aminopropyl)aminobuthyl) -2-(gamma-guanidino-fat acid-amido) - 2 -substituted-ethanamide
FR2554717B1 (fr) Comprimes pharmaceutiques a liberation etalee et procede pour les preparer
FR2628324B1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
FR2312195A1 (fr) Compositions de pesticides a support de gel, et procede pour les preparer
LU81318A1 (fr) Composition pharmaceutique pour nutrition parenterale
FR2565227B1 (fr) 1,24-dihydroxy-22-vitamines d3 et procede pour les preparer
PT76853B (fr) Procede de preparation de compositions pharmaceutiques a base de xylosides et lyxosides de base puriques et pyrimidiques
FR2559065B1 (fr) Composition pharmaceutique a biodisponibilite elevee a base d'acetate de medroxyprogesterone et procede pour la preparer
FR2457103B1 (fr) Procede pour preparer de l'interferon humain
IT8147537A0 (it) Composizione farmaceutica a cessione prolungata e procedimento per prepararla
IT1161135B (it) Contenitore rigido di cartone e procedimento ed apparecchiatura per la sua produzione
FR2351088A1 (fr) Procede pour la preparation d'amines tertiaires
FR2522668B1 (fr) Copolymeres-blocs a base de pivalolactone, et procede pour les preparer
FR2543958B1 (fr) Composes 2-thiacephem et procede pour les preparer
PT87672A (pt) Process for preparing a pharmaceutical composition
MA18628A1 (fr) Procede d'obtention de nouvelles compositions pharmaceutiques a base d'aryltrigluoroethanol
FR2561920B1 (fr) Nouvelles combinaisons de medicaments ayant un effet synergique a base de tiamuline et d'un aminoglycoside et procede pour les preparer
FR2549046B1 (fr) 6-desoxyanthracyclines et procede pour les preparer
PT77799A (fr) Procede de preparations de compositions fongicides a base de phosethyl al et cynoxanil
BE896217A (fr) Liposomes et procede pour les preparer
BE863700A (fr) Azetidinones et procede pour les preparer

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse